Stock Spotlight: Pro Medicus Limited (ASX:PME)

This week's Stock Spotlight is ASX-listed Pro Medicus Limited.


About Pro Medicus Limited.


Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centres, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualisation capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.


Source: Yahoo Finance



Key Stats

Source: Yahoo Finance. Data as of 07/08/25.


Price Performance

Growth Potential

  • Strong balance sheet position with no debt.
  • Proven and market leading technology (management believes they are 24 months ahead of competitors), with PME’s product commanding a price premium.
  • New contract wins (more win rates plus higher value per contract), increasing usage by existing clients and winning market share in the U.S. (penetration in the U.S. is still just 7%).
  • New product launches – Enterprise Imaging solutions and moving into other “ologies” such as cardiology and ophthalmology. Developing artificial intelligence (AI) capabilities. Management noted cardiology opportunity could be approx. 25-35% size of radiology total addressable market.
  • Leveraged to the digital health data thematic and industry’s transition to cloud.
  • Expansion into new geographies.
  • Potential M&A activity.

Key Risks


  • High valuation which subjects the stock price to more volatility.
  • Timing (long lead time to close contracts) and scale of new contract wins disappoints relative to market expectations.
  • Contract renewals (pricing pressure) and potential budget cuts at hospitals leading to the delay of software upgrades / investment.
  • Increasing competitive pressures (from large scale players and new entrants with innovative technology).
  • Systems reliability – data breach or drop in quality.
  • Regulatory / funding changes – reimbursement changes leading to lower imaging volumes.

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Is a Share Advisor

right for you?

October 22, 2025
About Ferrari NV Ferrari N.V., through its subsidiaries, engages in design, engineering, production, and sale of luxury performance sports cars worldwide. The company offers sports, track, one-off, and road cars, as well as supercars. It also provides spare parts and engines, as well as after sales, repair, maintenance, and restoration services for cars; and licenses its Ferrari brand to various producers and retailers of luxury and lifestyle goods. In addition, the company operates Ferrari museums in Modena and Maranello; Il Cavallino restaurant in Maranello; and theme parks in Abu Dhabi and Spain. Further, it provides direct or indirect finance and leasing services; range of financial and ancillary services; special financing arrangements; and operates franchised and owned Ferrari stores. The company was founded in 1947 and is headquartered in Maranello, Italy. Key Stats
October 20, 2025
With gold near record levels, discover what’s driving the rally and how it’s shaping global markets and investor behaviour.
October 17, 2025
About Amcor Plc Amcor plc, together with its subsidiaries, engages in the production and sale of packaging products in Europe, North America, Latin America, and the Asia Pacific. The company operates in two segments, Global Flexible Packaging Solutions and Global Rigid Packaging Solutions. The Global Flexible Packaging Solutions segment develops and supplies flexible packaging products, including polymer resin, aluminum, and fiber based flexible packaging products to the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries. The Global Rigid Packaging Solutions segment manufactures rigid packaging containers, closures, dispensing and pharma devices, and related products for the food and beverage applications. The company sells its products through its direct sales force. The company was incorporated in 1926 and is headquartered in Zurich, Switzerland. Key Stats
October 13, 2025
Heightened US–China trade tensions trigger a USD 2 trillion market sell-off. Explore the market fallout and the implications for investors.
October 10, 2025
Explore ways to gaining real estate exposure via REITs, shares and ETFs without buying property.
October 9, 2025
A closer look at the AI boom: investor psychology, market behaviour, and lessons from past bubbles.
October 8, 2025
About Constellation Energy Corp Constellation Energy Corporation produces and sells energy products and services in the United States. It operates through five segments: Mid-Atlantic, Midwest, New York, ERCOT, and Other Power Regions. The company offers electricity, natural gas, energy-related products, and sustainable solutions. It has approximately 31,676 megawatts of generating capacity consisting of nuclear, wind, solar, natural gas, and hydroelectric assets. The company serves distribution utilities, municipalities, cooperatives, and commercial, industrial, public sector, and residential customers. The company was incorporated in 2021 and is headquartered in Baltimore, Maryland. Key Stats
October 3, 2025
About Cameco Corp Cameco Corporation provides uranium for the generation of electricity. It operates through three segments: Uranium, Fuel Services, and Westinghouse. The Uranium segment engages in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment is involved in the refining, conversion, and fabrication of uranium concentrate, as well as purchase and sale of conversion services. The Westinghouse segment operates as a nuclear reactor technology original equipment manufacturer and a provider of products and services to commercial utilities and government agencies. It also provides outage and maintenance, engineering support, instrumentation and control equipment, and plant modification services, as well as components and parts to nuclear reactors. The company sells its uranium and fuel products and services to nuclear utilities in the Americas, Europe, and Asia. Cameco Corporation was incorporated in 1987 and is based in Saskatoon, Canada. Key Stats
October 2, 2025
About Innovative Industrial Properties Inc. Innovative Industrial Properties, Inc. is a real estate investment trust (REIT) focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated cannabis facilities. Key Stats
September 18, 2025
The Federal Reserve delivers a 25-basis-point cut, aiming to balance slowing growth with stubborn inflation. What does it mean for equities across Australia and the US?